| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.02 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |